Health Care M&A Deals, July 23, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. To subscribe to our Health Care M&A deals chart and more, visit our membership site. LevinPro is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets. Biotechnology AcquirerTargetPriceBioIVTTissue... Read More »
Health Care M&A Deals, July 16, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. To subscribe to our Health Care M&A deals chart and more, visit our membership site. LevinPro is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets. Behavioral Health Care AcquirerTargetPriceAutism... Read More »
Health Care M&A Deals, July 9, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week based on disclosed price is the acquisition of Vectura Group plc for $1.2 billion by Philip Morris International. Vectura is a provider of innovative inhaled drug delivery solutions that enable partners to bring their medicines to patients. The company has thirteen key inhaled and eleven non-inhaled products marketed by major global... Read More »
Second Quarter Healthcare M&A Heats Up
The second quarter of 2021 was another healthy period for dealmakers. Sure, there was technically a decline in deal volume compared with the first quarter, but the first three months of 2021 broke records. Dealmakers struck 542 transactions in the second quarter, an 11% decrease from the 611 announced in the first quarter. Not bad at all, especially when we remind ourselves that only 344 deals were announced in the second quarter of 2020. It seems like investors are trying to make up for the lost time. Transaction value, on the other hand, soared, hitting $126.1 billion in the second quarter, a 38% increase compared with the $91.3 billion disclosed in the first quarter and a staggering... Read More »